COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,585 Articles (22,905 medRxiv, 8,680 bioRxiv)

Most recent first Previous |  Page 800: Articles 7991-8000  | Next

Epidemiological Interactions of Influenza and SARS-CoV-2 within a University Population During Omicron B.1.1.529 Outbreak
Malampy, R., Ganz, T., DeOliveira, G. M., Le, C. T., Li, K. M., Auclair, J.
10.1101/2022.05.26.22275641 — Posted: 2022-05-27
Molecular Investigations of Selected Spike Protein Mutations in SARS-CoV-2: Delta and Omicron Variants and Omicron BA.2 Sub Variant
Roy, U.
10.1101/2022.05.25.493484 — Posted: 2022-05-26
How do local-level authorities engage in epidemic and pandemic preparedness activities and coordinate with higher levels of government? Survey results from 33 cities
Boyce, M. R., Asprilla, M. C., van Loenen, B., McClelland, A., Rojhani, A.
10.1101/2022.05.25.22275614 — Posted: 2022-05-26
Real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir against mortality, hospitalization, and in-hospital outcomes among community-dwelling, ambulatory COVID-19 patients during the BA.2.2 wave in Hong Kong: an observational study
Wong, C. K. H., Au, I. C. H., Lau, K. T. K., Lau, E. H. Y., Cowling, B. J., Leung, G. M.
10.1101/2022.05.26.22275631 — Posted: 2022-05-26
Virologic characterization of symptom rebound following nirmatrelvir-ritonavir treatment for COVID-19
Boucau, J., Uddin, R., Marino, C., Regan, J., Choudhary, M. C., Flynn, J. P., Chen, G., Stuckwisch, A. M., Mathews, J., Liew, M. Y., Singh, A., Reynolds, Z., Iyer, S. L., Chamberlin, G. C., Vyas, T. D., Vyas, J. M., Turbett, S. E., Li, J. Z., Lemieux, J. E., Barczak, A. K., Siedner, M. J.
10.1101/2022.05.24.22275326 — Posted: 2022-05-26
Noninvasive ventilation strategies for patients with severe or critical COVID-19: A rapid review of clinical outcomes
Kelly, S. E., Wells, G. A.
10.1101/2022.05.25.22275586 — Posted: 2022-05-26
COVID-19 pandemic impact on preterm birth and stillbirth rates associated with socioeconomic disparities: A quasi-experimental study
Aboulatta, L., Kowalec, K., Leong, C., Delaney, J., Falk, J., Alessi-Severini, S., Chateau, D., Tan, Q., Kearns, K., Raimondi, C., Lavu, A., Haidar, L., Vaccaro, C., Eltonsy, S.
10.1101/2022.05.25.22275592 — Posted: 2022-05-26
Impact of school closures and reopening on COVID-19 caseload in 6 cities of Pakistan: An Interrupted Time Series Analysis
Mueed, A., Ahmad, T., Abdullah, M., Sultan, F., Khan, A.
10.1101/2022.05.25.22275590 — Posted: 2022-05-26
A repeat pattern of founder events for SARS-CoV-2 variants in Alaska
Haan, T. J., Smith, L. K., DeRonde, S., House, E., Zidek, J., Puhak, D., Mullen, L., Redlinger, M., Parker, J., Barnes, B. M., Burkhead, J. L., Knall, C., Bortz, E., Chen, J., Drown, D. M.
10.1101/2022.05.25.22275610 — Posted: 2022-05-26
The emergence of variants with increased fitness accelerates the slowdown of genome sequence heterogeneity in the SARS CoV 2 coronavirus
Oliver, J. L., Bernaola-Galvan, P., Perfectti, F., Gomez-Martin, C., Castiglione, S., Raia, P., Verdu, M., Moya, A.
10.1101/2022.05.26.493529 — Posted: 2022-05-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).